Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Eli Lilly · Phase 3 · Completed · Enrollment 441

NCT06047548

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Tirzepatide 5 milligram (mg)n/rn/rn/rn/rn/r
Tirzepatide Maximum Tolerated Dosen/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.